Ligand-specific sequential regulation of transcription factors for differentiation of MCF-7 cells

BMC Genomics

Volumn 10, Issue , 2009, Pages

  Saeki, Yuko ^a,d   Endo, Takaho ^b   Ide, Kaori ^a   Nagashima, Takeshi ^a,d   Yumoto, Noriko ^a,d   Toyoda, Tetsuro ^b   Suzuki, Harukazu ^b   Hayashizaki, Yoshihide ^b   Sakaki, Yoshiyuki ^c   Okada Hatakeyama, Mariko ^a,d  

^a RIKEN   (Japan)

^b RIKEN YOKOHAMA INSTITUTE   (Japan)

^c TOYOHASHI UNIVERSITY OF TECHNOLOGY   (Japan)

^d Institute of Physical and Chemical Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EARLY GROWTH RESPONSE FACTOR; EARLY GROWTH RESPONSE FACTOR 4; EPIDERMAL GROWTH FACTOR; FOUR AND A HALF LIM DOMAINS 2; HEPATITIS DELTA ANTIGEN; HEPATITIS DELTA ANTIGEN INTERACTING PROTEIN A; MITOGEN ACTIVATED PROTEIN KINASE 1; NEU DIFFERENTIATION FACTOR; PROTEIN C FOS; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR AP 1; TRANSCRIPTION FACTOR FRA 1; UNCLASSIFIED DRUG; LIGAND;

ARTICLE; CELL DIFFERENTIATION; CELL STRAIN MCF 7; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; GENE CONTROL; GENE IDENTIFICATION; GENE SILENCING; HUMAN; HUMAN CELL; PREDICTION; PROTEIN EXPRESSION; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; TRANSCRIPTION REGULATION; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PHENOTYPE; POLYMERASE CHAIN REACTION; REPRODUCIBILITY; SIGNAL TRANSDUCTION; TIME; TUMOR CELL LINE;

CELL DIFFERENTIATION; CELL LINE, TUMOR; EPIDERMAL GROWTH FACTOR; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; LIGANDS; NEUREGULIN-1; PHENOTYPE; POLYMERASE CHAIN REACTION; REPRODUCIBILITY OF RESULTS; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSCRIPTION FACTORS;

EID: 71549132510     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-10-545     Document Type: Article

References (70)

1. Balmanno K, Cook SJ. Sustained MAP kinase activation is required for the expression of cyclin D1, p21Cip1 and a subset of AP-1 proteins in CCL39 cells. Oncogene 1999, 20:3085-3097.
2. Stein R, Orit S, Anderson DJ. The induction of a neural-specific gene, SCG10, by nerve growth factor in PC12 cells is transcriptional, protein synthesis dependent, and glucocorticoid inhibitable. Dev Biol 1988, 127:316-325. 10.1016/0012-1606(88)90318-1, 2837417.
3. Kovary K, Bravo R. Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol Cell Biol 1991, 11:2451-2459. 360007, 1901942.
4. Kovary K, Bravo R. Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins. Mol Cell Biol 1992, 12:5015-5023. 360434, 1406676.
5. Greenberg ME, Greene LA, Ziff EB. Nerve growth factor and epidermal growth factor induce rapid transient changes in proto-oncogene transcription in PC12 cells. J Biol Chem 1985, 260:14101-14110.
6. Milbrandt J. Nerve growth factor rapidly induces c-FOS mRNA in PC12 rat pheochromocytoma cells. Proc Natl Acad Sci USA 1986, 183:4789-4793.
7. Mehmet H, Morris C, Rozengurt E. Multiple synergistic signal transduction pathways regulate c-FOS expression in Swiss 3T3 cells: the role of cyclic AMP. Cell Growth Differ 1990, 1:293-298.
8. Fambrough D, McClure K, Kazlauskas A, Lander ES. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell 1999, 97:727-741. 10.1016/S0092-8674(00)80785-0, 10380925.
9. Vouret-Craviari V, Van Obberghen-Schilling E, Scimeca JC, Van Obberghen E, Pouysségur J. Differential activation of p44mapk (ERK1) by alpha-thrombin and thrombin-receptor peptide agonist. Biochem J 1993, 289:209-214. 1132151, 8380983.
10. Cook SJ, McCormick F. Kinetic and biochemical correlation between sustained p44ERK1 (44 kDa extracellular signal-regulated kinase 1) activation and lysophosphatidic acid-stimulated DNA synthesis in Rat-1 cells. Biochem J 1996, 320(Pt 1):237-245. 8947493, 1217923.
11. Weber JD, Raben DM, Phillips PJ, Baldassare JJ. Sustained activation of extracellular-signal-regulated kinase 1 (ERK1) is required for the continued expression of cyclin D1 in G1 phase. Biochem J 1997, 326:61-68. 1218637, 9337851.
12. Roovers K, Davey G, Zhu X, Bottazzi ME, Assoian RK. Alpha5beta1 integrin controls cyclin D1 expression by sustaining mitogen-activated protein kinase activity in growth factor-treated cells. Mol Biol Cell 1999, 10:3197-3204. 25578, 10512860.
13. Murphy LO, Smith S, Chen RH, Fingar DC, Blenis J. Molecular interpretation of ERK signal duration by immediate early gene products. Nat Cell Biol 2002, 4:556-564.
14. Chalmers CJ, Gilley R, March HN, Balmanno K, Cook SJ. The duration of ERK1/2 activity determines the activation of c-FOS and FRA-1 and the composition and quantitative transcriptional output of AP-1. Cell Signal 2007, 19:695-704. 10.1016/j.cellsig.2006.09.001, 17052890.
15. Murphy LO, MacKeigan JP, Blenis J. A network of immediate early gene products propagates subtle differences in mitogen-activated protein kinase signal amplitude and duration. Mol Cell Biol 2004, 24:144-153. 10.1128/MCB.24.1.144-153.2004, 303364, 14673150.
16. Cohen DR, Curran T. FRA-1: a serum-inducible, cellular immediate-early gene that encodes a fos-related antigen. Mol Cell Biol 1988, 8:2063-2069. 363385, 3133553.
17. Foletta VC, Sonobe MH, Suzuki T, Endo T, Iba H, Cohen DR. Cloning and characterisation of the mouse fra-2 gene. Oncogene 1994, 9:3305-3311.
18. Matsui M, Tokuhara M, Konuma Y, Nomura N, Ishizaki R. Isolation of human fos-related genes and their expression during monocyte-macrophage differentiation. Oncogene 1990, 5:249-255.
19. Nishina H, Sato H, Suzuki T, Sato M, Iba H. Isolation and characterization of fra-2, an additional member of the fos gene family. Proc Natl Acad Sci USA 1990, 87:3619-3623. 10.1073/pnas.87.9.3619, 53953, 2110368.
20. Zerial M, Toschi L, Ryseck RP, Schuermann M, Müller R, Bravo R. The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J 1989, 8:805-813. 400877, 2498083.
21. Hirai SI, Ryseck RP, Mechta F, Bravo R, Yaniv M. Characterization of junD: a new member of the jun proto-oncogene family. EMBO J 1989, 8:1433-1439. 400971, 2504580.
22. Nishimura T, Vogt PK. The avian cellular homolog of the oncogene jun. Oncogene 1988, 3:659-663.
23. Ryder K, Lanahan A, Perez-Albuerne E, Nathans D. jun-D: a third member of the jun gene family. Proc Natl Acad Sci USA 1989, 86:1500-1503. 10.1073/pnas.86.5.1500, 286724, 2493644.
24. Jacobs D, Glossip D, Xing H, Musli AJ, Kornfeld K. Multiple docking sites on substrate proteins form a modular system that mediates recognition by ERK MAP kinase. Genes Dev 1999, 13:163-175. 10.1101/gad.13.2.163, 316390, 9925641.
25. Nagashima T, Shimodaira H, Ide K, Nakakuki T, Tani Y, Takahashi K, Yumoto N, Hatakeyama M. Quantitative transcriptional control of ErbB receptor signaling undergoes graded to biphasic response for cell differentiation. J Biol Chem 2007, 282:4045-4056. 10.1074/jbc.M608653200, 17142811.
26. Suzuki H, Okunishi R, Hashizume W, Katayama S, Ninomiya N, Osato N, Sato K, Nakamura M, Iida J, Kanamori M, Hayashizaki H. Identification of region-specific transcription factor genes in the adult mouse brain by medium-scale real-time RT-PCR. FEBS Lett 2004, 573:214-218. 10.1016/j.febslet.2004.07.068, 15328000.
27. Larionov A, Krause A, Miller W. A standard curve based method for relative real time PCR data processing. BMC Bioinformatics 2005, 6:62-77. 10.1186/1471-2105-6-62, 1274258, 15780134.
28. Birtwistle MR, Hatakeyama M, Yumoto N, Ogunnaike BA, Hoek JB, Kholodenko BN. Ligand-dependent responses of the ErbB signaling network: experimental and modeling analyses. Mol Syst Biol 2007, 3:144. 10.1038/msb4100188, 2132449, 18004277.
29. Adiseshaiah P, Papaiahgari SR, Vuong H, Kalvakolanu DV, Reddy SP. Multiple cis-elements mediate the transcriptional activation of human FRA-1 by 12-O-tetradecanoylphorbol-13-acetate in bronchial epithelial cells. J Biol Chem 2003, 278:47423-47433. 10.1074/jbc.M303505200, 13679379.
30. Bakiri L, Matsuo K, Wisniewska M, Wagner EF, Yaniv M. Promoter specificity and biological activity of tethered AP-1 dimers. Mol Cell Biol 2002, 22:4952-4964. 10.1128/MCB.22.13.4952-4964.2002, 133900, 12052899.
31. Zipfel PF, Decker EL, Holst C, Skerka C. The human zinc finger protein EGR-4 acts as autoregulatory transcriptional repressor. Biochim Biophys Acta 1997, 1354:134-144.
32. Wieland GD, Nehmann N, Müller D, Eibel H, Siebenlist U, Sühnel J, Zipfel PF, Skerka C. Early growth response proteins EGR-4 and EGR-3 interact with immune inflammatory mediators NF-kappaB p50 and p65. J Cell Sci 2005, 118:3203-3212. 10.1242/jcs.02445, 16014385.
33. Tulchinsky E. Fos family members: regulation, structure and role in oncogenic transformation. Histol Histopathol 2000, 15:921-928.
34. Mechta F, Lallemand D, Pfarr CM, Yaniv M. Transformation by ras modifies AP1 composition and activity. Oncogene 1997, 14:837-847. 10.1038/sj.onc.1200900, 9047391.
35. Murakami M, Sonobe MH, Ui M, Kabuyama Y, Watanabe H, Wada T, Handa H, Iba H. Phosphorylation and high level expression of Fra-2 in v-src transformed cells: a pathway of activation of endogenous AP-1. Oncogene 1997, 14:2435-2444. 10.1038/sj.onc.1201077, 9188858.
36. Matsuo K, Owens JM, Tonko M, Elliott C, Chambers TJ, Wagner EF. FOSL-1 is a transcriptional target of c-FOS during osteoclast differentiation. Nat Genet 2000, 24:184-187. 10.1038/72855, 10655067.
37. Murakami M, Ui M, Iba H. Fra-2-positive autoregulatory loop triggered by mitogen-activated protein kinase (MAPK) and Fra-2 phosphorylation sites by MAPK. Cell Growth Differ 1999, 10:333-342.
38. Cook SJ, Aziz N, McMahon M. The repertoire of fos and jun proteins expressed during the G1 phase of the cell cycle is determined by the duration of mitogen-activated protein kinase activation. Mol Cell Biol 1999, 19:330-341. 83891, 9858557.
39. Casalino L, De Cesare D, Verde P. Accumulation of FRA-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization. Mol Cell Biol 2003, 23:4401-4415. 10.1128/MCB.23.12.4401-4415.2003, 12773579, 156136.
40. Fimia GM, De Cesare D, Sassone-Corsi P. A family of LIM-only transcriptional coactivators: tissue-specific expression and selective activation of CREB and CREM. Mol Cell Biol 2000, 20:8613-8622. 10.1128/MCB.20.22.8613-8622.2000, 102166, 11046156.
41. Morlon A, Sassone-Corsi P. The LIM-only protein FHL2 is a serum-inducible transcriptional coactivator of AP-1. Proc Natl Acad Sci USA 2003, 100:3977-3982. 10.1073/pnas.0735923100, 153033, 12644711.
42. Purcell NH, Darwis D, Bueno OF, Müller JM, Schüle R, Molkentin JD. Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol Cell Biol 2004, 24:1081-1095. 10.1128/MCB.24.3.1081-1095.2004, 14729955, 321437.
43. Bezy O, Elabd C, Cochet O, Petersen RK, Kristiansen K, Dani C, Ailhaud G, Amri EZ. Delta-interacting protein A, a new inhibitory partner of CCAAT/enhancer-binding protein beta, implicated in adipocyte differentiation. J Biol Chem 2005, 280:11432-11438. 10.1074/jbc.M411741200, 15644333.
44. Chang JT, Nevins JR. GATHER: a systems approach to interpreting genomic signatures. Bioinformatics 2006, 22:2926-2933. 10.1093/bioinformatics/btl483, 17000751.
45. Ashburner M, Ball CA, Blake JA, Botstein D, Butler H, Cherry JM, Davis AP, Dolinski K, Dwight SS, Eppig JT, Harris MA, Hill DP, Issel-Tarver L, Kasarskis A, Lewis S, Matese JC, Richardson JE, Ringwald M, Rubin GM, Sherlock G. Gene ontology: tool for the unification of biology. Nat Genet 2000, 25:25-29. 10.1038/75556, 10802651.
46. Reusch JE, Colton LA, Klemm DJ. CREB activation induces adipogenesis in 3T3-L1 cells. Mol Cell Biol 2000, 20:1008-1020. 10.1128/MCB.20.3.1008-1020.2000, 85218, 10629058.
47. Brazas R, Ganem D. A cellular homolog of hepatitis delta antigen: implications for viral replication and evolution. Science 1996, 274:90-94. 10.1126/science.274.5284.90, 8810253.
48. Kumahara E, Ebihara T, Saffen D. Nerve growth factor induces zif268 gene expression via MAPK-dependent and -independent pathways in PC12D cells. J Biochem 1999, 125:541-553.
49. Nagashima T, Suzuki T, Kondo S, Kuroki Y, Takahashi K, Ide K, Yumoto N, Hasegawa A, Toyoda T, Kojima T, Konagaya A, Suzuki H, Hayashizaki Y, Sakaki Y, Hatakeyama M. Integrative genome-wide expression analysis bears evidence of estrogen receptor-independent transcription in heregulin-stimulated MCF-7 cells. PLoS ONE 2008, 3:e1803. 10.1371/journal.pone.0001803, 2266794, 18350142.
50. Schade AE, Levine AD. Cutting edge: extracellular signal-regulated kinases 1/2 function as integrators of TCR signal strength. J Immunol 2004, 172:5828-5832.
51. Adiseshaiah P, Peddakama S, Zhang Q, Kalvakolanu DV, Reddy SP. Mitogen regulated induction of FRA-1 proto-oncogene is controlled by the transcription factors binding to both serum and TPA response elements. Oncogene 2005, 24:4193-4205. 10.1038/sj.onc.1208583, 15806162.
52. Bergers G, Graninger P, Braselmann S, Wrighton C, Busslinger M. Transcriptional activation of the fra-1 gene by AP-1 is mediated by regulatory sequences in the first intron. Mol Cell Biol 1995, 15:3748-3758. 230613, 7791782.
53. Angel P, Karin M. The role of Jun, Fos and the AP-1 complex in cell-proliferation and transformation. Biochim Biophys Acta 1991, 1072:129-157.
54. Chinenov Y, Kerppola TK. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001, 20:2438-2452. 10.1038/sj.onc.1204385, 11402339.
55. Eriksson M, Taskinen M, Leppä S. Mitogen activated protein kinase-dependent activation of c-JUN and c-FOS is required for neuronal differentiation but not for growth and stress response in PC12 cells. J Cell Physiol 2007, 210:538-548. 10.1002/jcp.20907, 17111371.
56. Song Y, Song S, Zhang D, Zhang Y, Chen L, Qian L, Shi M, Zhao H, Jiang Z, Guo N. An association of a simultaneous nuclear and cytoplasmic localization of FRA-1 with breast malignancy. BMC Cancer 2006, 6:298. 10.1186/1471-2407-6-298, 1770932, 17192200.
57. Chiappetta G, Ferraro A, Botti G, Monaco M, Pasquinelli R, Vuttariello E, Arnaldi L, Di Bonito M, D'Aiuto G, Pierantoni GM, Fusco A. FRA-1 protein overexpression is a feature of hyperplastic and neoplastic breast disorders. BMC Cancer 2007, 7:17. 10.1186/1471-2407-7-17, 1796888, 17254320.
58. Zajchowski DA, Bartholdi MF, Gong Y, Webster L, Liu HL, Munishkin A, Beauheim C, Harvey S, Ethier SP, Johnson PH. Identification of gene expression profiles that predict the aggressive behavior of breast cancer cells. Cancer Res 2001, 61:5168-5178.
59. Schreiber M, Poirier C, Franchi A, Kurzbauer R, Guenet JL, Carle GF, Wagner EF. Structure and chromosomal assignment of the mouse fra-1 gene, and its exclusion as a candidate gene for oc (osteosclerosis). Oncogene 1997, 15:1171-1178. 10.1038/sj.onc.1201460, 9294610.
60. Purcell NH, Darwis D, Bueno OF, Müller JM, Schüle R, Molkentin JD. Extracellular signal-regulated kinase 2 interacts with and is negatively regulated by the LIM-only protein FHL2 in cardiomyocytes. Mol Cell Biol 2004, 24:1081-1095. 10.1128/MCB.24.3.1081-1095.2004, 321437, 14729955.
61. Wang J, Yang Y, Xia HH, Gu Q, Lin MC, Jiang B, Peng Y, Li G, An X, Zhang Y, Zhuang Z, Zhang Z, Kung HF, Wong BC. Suppression of FHL2 expression induces cell differentiation and inhibits gastric and colon carcinogenesis. Gastroenterology 2007, 132:1066-1076. 10.1053/j.gastro.2006.12.004, 17383428.
62. Treinies I, Paterson HF, Hooper S, Wilson R, Marshall CJ. Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal to stimulate DNA synthesis. Mol Cell Biol 1999, 19:321-329. 83890, 9858556.
63. Dedieu S, Lefebvre P. Retinoids interfere with the AP1 signalling pathway in human breast cancer cells. Cell Signal 2006, 18:889-898. 10.1016/j.cellsig.2005.08.001, 16176868.
64. Marino M, Galluzzo P, Ascenzi P. Estrogen signaling multiple pathways to impact gene transcription. Curr Genomics 2006, 7:497-508. 10.2174/138920206779315737, 2269003, 18369406.
65. Casalino L, De Cesare D, Verde P. Accumulation of FRA-1 in ras-transformed cells depends on both transcriptional autoregulation and MEK-dependent posttranslational stabilization. Mol Cell Biol 2003, 23:4401-4415. 10.1128/MCB.23.12.4401-4415.2003, 156136, 12773579.
66. Lee SH, Nam HS. TNF alpha-induced down-regulation of estrogen receptor alpha in MCF-7 breast cancer cells. Mol Cells 2008, 26(3):285-290. Epub 2008 May 14, 18483465.
67. Freeman M. Eye development: stable cell fate decisions in insect colour vision. Curr Biol 2005, 15:R924-R926. 10.1016/j.cub.2005.10.062, 16303550.
68. Lill NL, Douillard P, Awwad RA, Ota S, Lupher ML, Miyake S, Meissner-Lula N, Hsu VW, Band H. The evolutionarily conserved N-terminal region of Cbl is sufficient to enhance down-regulation of the epidermal growth factor receptor. J Biol Chem 2000, 275:367-377. 10.1074/jbc.275.1.367, 10617627.
69. Santos SD, Verveer PJ, Bastiaens PI. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate. Nat Cell Biol 2007, 9:324-330. 10.1038/ncb1543, 17310240.
70. Vial E, Marshall CJ. Elevated ERK-MAP kinase activity protects the FOS family member FRA-1 against proteasomal degradation in colon carcinoma cells. J Cell Sci 2003, 116:4957-4963. 10.1242/jcs.00812, 14625389.